embody Reviews
Compounded semaglutide and tirzepatide at a flat monthly price - no commitment, shipped in 1-2 days
Last updated: Sep 27, 2026
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
embody is our top pick because it combines the two things that matter most for cash-pay GLP-1 patients - a low, flat price and no lock-in - with the fastest delivery we found. $69/month semaglutide and $119/month tirzepatide on a month-to-month basis is hard to beat, and LegitScript certification plus licensed clinicians on every intake gives it a solid compliance footing.
The trade-offs are real: compounded GLP-1s are not FDA-approved, support reviews are mixed, and it will not help you use insurance. If you want brand-name medication or have coverage, choose ro; if you are cash-pay and want to start this week, embody is the one to beat.
Results vary, and a licensed clinician decides whether a GLP-1 is right for you. This review is general information, not medical advice.
embody is a cash-pay GLP-1 telehealth service built around two things most people care about first: price and speed. A licensed US clinician reviews your online intake, and if a GLP-1 is appropriate, compounded semaglutide or tirzepatide ships cold-chain packed within 1-2 days.
There is no annual contract to sign - pricing is flat and month-to-month, so you can stop at any point. It is also LegitScript-certified and sources medication from state-licensed 503A compounding pharmacies.
The catch is the one that applies to every compounded program: these medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. This review covers what embody costs, how it works, and who should - and should not - pick it.
Key Features
- Compounded semaglutide $69/month and tirzepatide $119/month
- Month-to-month pricing - no commitment, cancel anytime
- Ships in 1-2 days, cold-chain packed, free shipping
- Weekly injection, plus a daily oral (compounded) option
- Licensed US clinicians review every intake; LegitScript-certified
- Messaging with the care team between check-ins
Treatment Options
- Compounded semaglutide (weekly injection)
- Compounded tirzepatide (weekly injection)
- Daily oral compounded GLP-1 option
- Clinician dose adjustments and care-team messaging
Pricing
Semaglutide
Month-to-month, cancel anytimeCompounded semaglutide (weekly injection)
- Flat monthly price
- Free cold-chain shipping
- Clinician review included
Tirzepatide
Month-to-month, cancel anytimeCompounded tirzepatide (weekly injection)
- Flat monthly price
- Ships in 1-2 days
- Care-team messaging
embody uses flat monthly pricing with no commitment: compounded semaglutide is $69/month (regular $79) and compounded tirzepatide is $119/month (regular $129). Shipping is free.
It is cash-pay - no insurance is required or billed - and HSA/FSA funds can be used. Because you are not locked into a multi-month plan, $69/month is the lowest no-commitment semaglutide price among the providers we rank.
The discounted rates are promotional, so confirm the current price at checkout. Remember that compounded GLP-1s are not FDA-approved.
How embody Works
- 1Step 1
Complete the online intake
Answer questions about your weight, health history and medications. Be thorough - a personal or family history of medullary thyroid cancer or MEN2, pancreatitis or pregnancy plans matters.
- 2Step 2
Clinician review
A licensed US clinician reviews your answers and decides whether a GLP-1 is appropriate, which medication fits and the starting dose.
- 3Step 3
Delivery in 1-2 days
If prescribed, your medication ships cold-chain packed from a state-licensed 503A pharmacy, with free shipping.
- 4Ongoing
Check-ins and dose changes
Message the care team between check-ins as your dose is stepped up. Cancel any month - there is no commitment.
Pros
- Lowest no-commitment price on our list - semaglutide $69/month, tirzepatide $119/month
- Fastest delivery we found: 1-2 days, cold-chain packed, free shipping
- No contract - you can stop or cancel whenever you want
- LegitScript-certified, with licensed US clinicians and 503A pharmacies
- An oral option for people who would rather avoid injections
Cons
- Compounded medication only - not FDA-approved, and not reviewed by the FDA for safety, effectiveness or quality
- Cash-pay only - no help using insurance for brand-name medication
- Mixed Trustpilot rating (3.8 / 5 from 8,398 reviews), with complaints centering on shipping delays and support response times
- Promotional prices can revert to the regular $79 / $129 rates
Who It's Best For
- People paying cash who want the lowest price without a long commitment
- Anyone who wants to start quickly - medication in 1-2 days
- Those who want an oral option as well as injections
- Skip it if you have insurance that covers Wegovy or Zepbound, or you only want FDA-approved medication - look at ro instead
Final Verdict
embody is our top pick because it combines the two things that matter most for cash-pay GLP-1 patients - a low, flat price and no lock-in - with the fastest delivery we found. $69/month semaglutide and $119/month tirzepatide on a month-to-month basis is hard to beat, and LegitScript certification plus licensed clinicians on every intake gives it a solid compliance footing.
The trade-offs are real: compounded GLP-1s are not FDA-approved, support reviews are mixed, and it will not help you use insurance. If you want brand-name medication or have coverage, choose ro; if you are cash-pay and want to start this week, embody is the one to beat.
Results vary, and a licensed clinician decides whether a GLP-1 is right for you. This review is general information, not medical advice.
embody Review: FAQs
Is embody legit?
embody is a cash-pay GLP-1 telehealth service built around two things most people care about first: price and speed. A licensed US clinician reviews your online intake, and if a GLP-1 is appropriate, compounded semaglutide or tirzepatide ships cold-chain packed within 1-2 days. There is no annual contract to sign - pricing is flat and month-to-month, so you can stop at any point. It is also LegitScript-certified and sources medication from state-licensed 503A compounding pharmacies. The catch is the one that applies to every compounded program: these medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. This review covers what embody costs, how it works, and who should - and should not - pick it.
How much does embody cost?
embody uses flat monthly pricing with no commitment: compounded semaglutide is $69/month (regular $79) and compounded tirzepatide is $119/month (regular $129). Shipping is free. It is cash-pay - no insurance is required or billed - and HSA/FSA funds can be used. Because you are not locked into a multi-month plan, $69/month is the lowest no-commitment semaglutide price among the providers we rank. The discounted rates are promotional, so confirm the current price at checkout. Remember that compounded GLP-1s are not FDA-approved.
What treatments does embody offer?
embody offers Compounded semaglutide (weekly injection), Compounded tirzepatide (weekly injection), Daily oral compounded GLP-1 option, Clinician dose adjustments and care-team messaging.
Who is embody best for?
embody is best for People paying cash who want the lowest price without a long commitment; Anyone who wants to start quickly - medication in 1-2 days; Those who want an oral option as well as injections; Skip it if you have insurance that covers Wegovy or Zepbound, or you only want FDA-approved medication - look at ro instead.
Is embody worth it?
embody is our top pick because it combines the two things that matter most for cash-pay GLP-1 patients - a low, flat price and no lock-in - with the fastest delivery we found. $69/month semaglutide and $119/month tirzepatide on a month-to-month basis is hard to beat, and LegitScript certification plus licensed clinicians on every intake gives it a solid compliance footing. The trade-offs are real: compounded GLP-1s are not FDA-approved, support reviews are mixed, and it will not help you use insurance. If you want brand-name medication or have coverage, choose ro; if you are cash-pay and want to start this week, embody is the one to beat. Results vary, and a licensed clinician decides whether a GLP-1 is right for you. This review is general information, not medical advice.
Related
Sources & methodology
We built this review of embody from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- embody - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 2.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - U.S. Food & Drug Administration
- 3.Wegovy (semaglutide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 4.Zepbound (tirzepatide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 5.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding et al. - New England Journal of Medicine, 2021;384:989-1002
- 6.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) - Jastreboff et al. - New England Journal of Medicine, 2022;387:205-216
- 7.Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) - Aronne et al. - New England Journal of Medicine, 2025
- 8.Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension - Wilding et al. - Diabetes, Obesity and Metabolism, 2022
- 9.Prescription Medications to Treat Overweight & Obesity - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.